The AIDS epidemic: the spread of a deadly disease in the biotech era.
In the last two decades we have witnessed the progression of a newly introduced infection in humans. It is sobering that despite a world-wide effort and the tremendous progression of technical capabilities and scientific knowledge we are still not able to control the global epidemic of HIV. In 2004 more than 40 million people were infected. Educational approaches to modify risk-taking behavior is still the most critical component of prevention and the most important measure to limit the spread of the infection. Vaccine development, which is still far from promising, is probably the only way to control the disease in the future.
Noë
A
A
AIDS Reference Laboratory, Ghent University Hospital, Gent, Belgium. ann.noe@Ugent.be
Verhofstede
C
C
Plum
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology*; D000328:Adult; D000349:Africa / Q000453:epidemiology; D023241:Antiretroviral Therapy, Highly Active; D001208:Asia / Q000453:epidemiology; D001315:Australia / Q000453:epidemiology; D002648:Child; D004196:Disease Outbreaks / Q000706:statistics & numerical data*; D005060:Europe / Q000453:epidemiology; D005260:Female; D015497:HIV-1 / Q000187:drug effects; D015498:HIV-2 / Q000187:drug effects; D006801:Humans; D007843:Latin America / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009656:North America / Q000453:epidemiology; D015995:Prevalence; D013020:South America / Q000453:epidemiology; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine